DnB Asset Management AS Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

DnB Asset Management AS grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 100,531 shares of the medical equipment provider’s stock after acquiring an additional 7,406 shares during the period. DnB Asset Management AS’s holdings in Intuitive Surgical were worth $52,473,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Norges Bank acquired a new position in Intuitive Surgical during the fourth quarter worth $2,401,493,000. Proficio Capital Partners LLC boosted its position in Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $313,769,000. Wilmington Savings Fund Society FSB increased its holdings in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Finally, Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $507.90 on Friday. The business’s 50-day moving average is $558.29 and its two-hundred day moving average is $532.25. The firm has a market capitalization of $180.90 billion, a PE ratio of 79.24, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.